Share Price and Basic Stock Data
Last Updated: November 22, 2025, 10:30 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Aimco Pesticides Ltd operates in the agrochemicals and pesticides sector, where it has reported a market capitalization of ₹60.4 Cr and a share price of ₹61.7. The company’s revenue trajectory has demonstrated volatility, with sales figures fluctuating significantly over recent quarters. Sales for the quarter ending June 2022 were ₹70.58 Cr, declining to ₹30.79 Cr by December 2022, before rebounding to ₹80.47 Cr in September 2023. However, the trailing twelve months (TTM) revenue stood at ₹197 Cr, which reflects a decline from ₹312 Cr in the fiscal year ended March 2022. This downward trend in revenue is concerning, especially given the sector’s potential for growth. The agrochemical sector in India is expected to reach a market size of approximately ₹3 lakh Cr by 2025, indicating a competitive landscape that Aimco must navigate effectively. The company’s ability to stabilize and grow its sales will be crucial in maintaining market relevance and investor interest.
Profitability and Efficiency Metrics
Aimco Pesticides Ltd has faced significant challenges in maintaining profitability, with reported operating profit margins (OPM) consistently negative in recent quarters, notably standing at -3.01% for the latest quarter. The company’s net profit has shown a troubling trend, recording a loss of ₹10 Cr in the fiscal year ending March 2025, compared to a profit of ₹11 Cr in March 2022. This deterioration is evident in its return on equity (ROE) of 22.9% and return on capital employed (ROCE) of 12.7%, which are substantially below industry norms. The interest coverage ratio (ICR) is concerning as well, reported at -0.77x, indicating that the company’s earnings are insufficient to cover interest expenses. Furthermore, the cash conversion cycle (CCC) of -8 days suggests operational inefficiencies in managing working capital. Overall, these profitability metrics highlight the urgent need for Aimco to streamline operations and enhance cost management to return to positive profit margins.
Balance Sheet Strength and Financial Ratios
The balance sheet of Aimco Pesticides Ltd reveals a lack of reserves and borrowings, which can be interpreted as both a strength and a weakness. The absence of borrowings implies a lower financial risk; however, it also indicates a potential limitation on growth opportunities. The company’s current ratio stands at 0.95, slightly below the ideal benchmark of 1, suggesting potential liquidity issues. The book value per share is reported at ₹30.55, down from ₹52.69 in the previous fiscal year, reflecting a declining asset base. Furthermore, the total debt to equity ratio is reported at 0.65, indicating a moderate level of leverage which, while not excessive, does warrant careful monitoring. The price-to-book value (P/BV) ratio of 2.50x indicates that the stock is trading at a premium relative to its book value, which may deter value-focused investors. These financial ratios suggest that while Aimco is not over-leveraged, its declining asset value and liquidity concerns could pose challenges in securing future financing or investments.
Shareholding Pattern and Investor Confidence
Aimco Pesticides Ltd exhibits a diverse shareholding structure, with promoters holding 54.45% of the company’s shares, indicating a strong insider commitment to the business. Institutional investors have minimal involvement, with foreign institutional investors (FIIs) and domestic institutional investors (DIIs) holding just 0.04% and 0.03% respectively. This lack of institutional interest may reflect the market’s cautious stance regarding the company’s recent financial performance. The public shareholding stands at 45.48%, which suggests a relatively high level of retail investor participation, with 11,354 total shareholders. However, the decline in the number of shareholders from 12,010 in December 2022 to the current figure indicates a potential erosion of investor confidence. The shareholding pattern suggests that while promoter confidence remains strong, the company must work to attract institutional investors and retain retail confidence through improved performance and strategic initiatives.
Outlook, Risks, and Final Insight
The outlook for Aimco Pesticides Ltd hinges on its ability to turnaround its operational and financial performance. Key strengths include the absence of debt, which provides a buffer against financial distress, and a stable promoter holding that may ensure alignment of interests. However, significant risks include ongoing losses, negative profitability margins, and operational inefficiencies, which could deter potential investors. To mitigate these risks, Aimco must implement strategic cost management practices and enhance operational efficiencies to restore profitability. Additionally, increasing product innovation and market penetration in the growing agrochemical sector could provide avenues for growth. Should the company successfully execute these strategies, it may regain investor confidence and improve its financial metrics, thereby positioning itself favorably in a competitive market landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Aimco Pesticides Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 6,258 Cr. | 1,452 | 2,196/1,440 | 15.6 | 487 | 0.41 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 860 Cr. | 253 | 391/165 | 17.7 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 64.7 Cr. | 124 | 149/56.6 | 11.6 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,250 Cr. | 252 | 365/228 | 123 | 54.9 | 0.06 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 710 Cr. | 300 | 670/244 | 55.5 | 342 | 1.00 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,119.20 Cr | 1,490.43 | 32.33 | 472.46 | 0.45% | 15.21% | 19.87% | 7.25 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 70.58 | 63.32 | 30.79 | 41.55 | 45.92 | 80.47 | 44.25 | 36.74 | 39.78 | 55.32 | 50.72 | 52.57 | 47.86 |
| Expenses | 65.77 | 60.28 | 31.89 | 45.42 | 52.22 | 77.15 | 44.77 | 40.63 | 40.12 | 54.98 | 48.73 | 57.34 | 49.30 |
| Operating Profit | 4.81 | 3.04 | -1.10 | -3.87 | -6.30 | 3.32 | -0.52 | -3.89 | -0.34 | 0.34 | 1.99 | -4.77 | -1.44 |
| OPM % | 6.81% | 4.80% | -3.57% | -9.31% | -13.72% | 4.13% | -1.18% | -10.59% | -0.85% | 0.61% | 3.92% | -9.07% | -3.01% |
| Other Income | 0.24 | 0.51 | 0.22 | 0.09 | 0.38 | 0.10 | 0.18 | 0.47 | 0.03 | 0.03 | 0.04 | 0.03 | 0.09 |
| Interest | 0.32 | 0.18 | 0.33 | 1.67 | 0.98 | 0.61 | 0.53 | 0.53 | 0.61 | 0.66 | 0.52 | 1.30 | 0.51 |
| Depreciation | 0.96 | 1.07 | 1.11 | 0.92 | 1.00 | 1.04 | 1.06 | 1.06 | 1.06 | 1.05 | 0.98 | 0.90 | 0.79 |
| Profit before tax | 3.77 | 2.30 | -2.32 | -6.37 | -7.90 | 1.77 | -1.93 | -5.01 | -1.98 | -1.34 | 0.53 | -6.94 | -2.65 |
| Tax % | 26.79% | 24.35% | -23.71% | -25.59% | -24.81% | 23.73% | -24.87% | -25.15% | -24.24% | -26.12% | 15.09% | -22.91% | -32.83% |
| Net Profit | 2.75 | 1.74 | -1.76 | -4.75 | -5.94 | 1.35 | -1.46 | -3.75 | -1.50 | -0.99 | 0.45 | -5.34 | -1.78 |
| EPS in Rs | 2.87 | 1.82 | -1.84 | -4.96 | -6.20 | 1.41 | -1.52 | -3.91 | -1.57 | -1.03 | 0.47 | -5.46 | -1.82 |
Last Updated: August 20, 2025, 12:15 am
Below is a detailed analysis of the quarterly data for Aimco Pesticides Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 47.86 Cr.. The value appears to be declining and may need further review. It has decreased from 52.57 Cr. (Mar 2025) to 47.86 Cr., marking a decrease of 4.71 Cr..
- For Expenses, as of Jun 2025, the value is 49.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 57.34 Cr. (Mar 2025) to 49.30 Cr., marking a decrease of 8.04 Cr..
- For Operating Profit, as of Jun 2025, the value is -1.44 Cr.. The value appears strong and on an upward trend. It has increased from -4.77 Cr. (Mar 2025) to -1.44 Cr., marking an increase of 3.33 Cr..
- For OPM %, as of Jun 2025, the value is -3.01%. The value appears strong and on an upward trend. It has increased from -9.07% (Mar 2025) to -3.01%, marking an increase of 6.06%.
- For Other Income, as of Jun 2025, the value is 0.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.03 Cr. (Mar 2025) to 0.09 Cr., marking an increase of 0.06 Cr..
- For Interest, as of Jun 2025, the value is 0.51 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.30 Cr. (Mar 2025) to 0.51 Cr., marking a decrease of 0.79 Cr..
- For Depreciation, as of Jun 2025, the value is 0.79 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.90 Cr. (Mar 2025) to 0.79 Cr., marking a decrease of 0.11 Cr..
- For Profit before tax, as of Jun 2025, the value is -2.65 Cr.. The value appears strong and on an upward trend. It has increased from -6.94 Cr. (Mar 2025) to -2.65 Cr., marking an increase of 4.29 Cr..
- For Tax %, as of Jun 2025, the value is -32.83%. The value appears to be improving (decreasing) as expected. It has decreased from -22.91% (Mar 2025) to -32.83%, marking a decrease of 9.92%.
- For Net Profit, as of Jun 2025, the value is -1.78 Cr.. The value appears strong and on an upward trend. It has increased from -5.34 Cr. (Mar 2025) to -1.78 Cr., marking an increase of 3.56 Cr..
- For EPS in Rs, as of Jun 2025, the value is -1.82. The value appears strong and on an upward trend. It has increased from -5.46 (Mar 2025) to -1.82, marking an increase of 3.64.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:01 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 140 | 164 | 96 | 98 | 109 | 197 | 184 | 176 | 312 | 207 | 208 | 198 | 197 |
| Expenses | 137 | 159 | 91 | 88 | 105 | 190 | 175 | 169 | 294 | 204 | 215 | 201 | 204 |
| Operating Profit | 3 | 4 | 4 | 11 | 4 | 7 | 9 | 7 | 18 | 3 | -7 | -3 | -7 |
| OPM % | 2% | 3% | 4% | 11% | 4% | 3% | 5% | 4% | 6% | 1% | -3% | -1% | -4% |
| Other Income | 0 | 0 | 1 | 2 | 5 | 7 | 4 | 3 | 1 | 1 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 1 | 2 | 4 | 1 | 2 | 3 | 3 | 3 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 4 | 4 | 4 | 4 |
| Profit before tax | 2 | 3 | 4 | 12 | 8 | 11 | 8 | 3 | 14 | -3 | -13 | -10 | -13 |
| Tax % | 77% | 10% | -9% | 3% | 37% | 30% | 32% | 33% | 27% | -23% | -25% | -24% | |
| Net Profit | 0 | 3 | 5 | 11 | 5 | 8 | 5 | 2 | 11 | -2 | -10 | -7 | -10 |
| EPS in Rs | 0.44 | 3.35 | 5.01 | 12.42 | 5.28 | 8.27 | 5.72 | 2.37 | 11.00 | -2.10 | -10.22 | -7.55 | -10.45 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 19% | 18% | 26% | 42% | 18% | -48% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 66.67% | 120.00% | -54.55% | 60.00% | -37.50% | -60.00% | 450.00% | -118.18% | -400.00% | 30.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 53.33% | -174.55% | 114.55% | -97.50% | -22.50% | 510.00% | -568.18% | -281.82% | 430.00% |
Aimco Pesticides Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 2% |
| 3 Years: | -14% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 2% |
| 3 Years: | -27% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -3% |
| 3 Years: | -16% |
| Last Year: | -23% |
Last Updated: September 5, 2025, 2:11 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 91 | 72 | 95 | 63 | 55 | 29 | 57 | 54 | 48 | 43 | 82 | 92 |
| Inventory Days | 47 | 25 | 95 | 102 | 122 | 106 | 148 | 160 | 115 | 177 | 110 | 174 |
| Days Payable | 125 | 107 | 197 | 161 | 145 | 116 | 170 | 188 | 161 | 174 | 177 | 274 |
| Cash Conversion Cycle | 13 | -10 | -6 | 3 | 31 | 19 | 36 | 25 | 2 | 47 | 15 | -8 |
| Working Capital Days | -15 | -7 | -1 | 1 | 37 | 27 | 26 | 30 | 19 | 26 | -4 | -17 |
| ROCE % | 52% | 168% | 44% | 90% | 36% | 37% | 24% | 16% | 31% | -1% | -18% | -13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -7.55 | -10.48 | -2.28 | 11.12 | 2.19 |
| Diluted EPS (Rs.) | -7.55 | -10.48 | -2.28 | 11.12 | 2.19 |
| Cash EPS (Rs.) | -3.22 | -6.03 | 1.49 | 13.98 | 4.48 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.55 | 36.55 | 48.30 | 52.69 | 42.58 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.55 | 36.55 | 48.30 | 52.69 | 42.58 |
| Revenue From Operations / Share (Rs.) | 203.15 | 217.08 | 215.18 | 325.59 | 183.35 |
| PBDIT / Share (Rs.) | -2.46 | -6.69 | 3.36 | 19.55 | 10.21 |
| PBIT / Share (Rs.) | -6.64 | -11.15 | -0.40 | 16.69 | 7.91 |
| PBT / Share (Rs.) | -9.80 | -13.90 | -2.92 | 15.15 | 3.33 |
| Net Profit / Share (Rs.) | -7.40 | -10.48 | -2.28 | 11.12 | 2.19 |
| NP After MI And SOA / Share (Rs.) | -7.40 | -10.48 | -2.28 | 11.12 | 2.19 |
| PBDIT Margin (%) | -1.20 | -3.08 | 1.56 | 6.00 | 5.56 |
| PBIT Margin (%) | -3.26 | -5.13 | -0.19 | 5.12 | 4.31 |
| PBT Margin (%) | -4.82 | -6.40 | -1.35 | 4.65 | 1.81 |
| Net Profit Margin (%) | -3.64 | -4.82 | -1.05 | 3.41 | 1.19 |
| NP After MI And SOA Margin (%) | -3.64 | -4.82 | -1.05 | 3.41 | 1.19 |
| Return on Networth / Equity (%) | -24.24 | -28.68 | -4.72 | 21.11 | 5.14 |
| Return on Capital Employeed (%) | -19.46 | -26.59 | -0.79 | 30.28 | 16.65 |
| Return On Assets (%) | -4.11 | -6.71 | -1.50 | 6.38 | 1.57 |
| Long Term Debt / Equity (X) | 0.01 | 0.05 | 0.00 | 0.00 | 0.05 |
| Total Debt / Equity (X) | 0.65 | 0.52 | 0.27 | 0.00 | 0.22 |
| Asset Turnover Ratio (%) | 1.22 | 1.41 | 1.32 | 2.08 | 1.34 |
| Current Ratio (X) | 0.95 | 0.99 | 1.16 | 1.20 | 1.19 |
| Quick Ratio (X) | 0.44 | 0.52 | 0.35 | 0.51 | 0.49 |
| Inventory Turnover Ratio (X) | 2.60 | 2.34 | 2.42 | 3.22 | 2.34 |
| Dividend Payout Ratio (NP) (%) | 0.00 | -9.53 | -87.69 | 8.99 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.00 | -16.59 | 134.46 | 7.15 | 0.00 |
| Earning Retention Ratio (%) | 0.00 | 109.53 | 187.69 | 91.01 | 0.00 |
| Cash Earning Retention Ratio (%) | 0.00 | 116.59 | -34.46 | 92.85 | 0.00 |
| Interest Coverage Ratio (X) | -0.77 | -2.42 | 1.34 | 12.71 | 2.23 |
| Interest Coverage Ratio (Post Tax) (X) | -1.34 | -2.80 | 0.09 | 8.23 | 1.48 |
| Enterprise Value (Cr.) | 89.51 | 101.25 | 115.79 | 128.41 | 90.12 |
| EV / Net Operating Revenue (X) | 0.45 | 0.48 | 0.56 | 0.41 | 0.51 |
| EV / EBITDA (X) | -37.27 | -15.80 | 35.98 | 6.85 | 9.21 |
| MarketCap / Net Operating Revenue (X) | 0.37 | 0.41 | 0.50 | 0.42 | 0.48 |
| Retention Ratios (%) | 0.00 | 109.53 | 187.69 | 91.00 | 0.00 |
| Price / BV (X) | 2.50 | 2.48 | 2.27 | 2.63 | 2.09 |
| Price / Net Operating Revenue (X) | 0.37 | 0.41 | 0.50 | 0.42 | 0.48 |
| EarningsYield | -0.09 | -0.11 | -0.02 | 0.08 | 0.02 |
After reviewing the key financial ratios for Aimco Pesticides Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -7.55. This value is below the healthy minimum of 5. It has increased from -10.48 (Mar 24) to -7.55, marking an increase of 2.93.
- For Diluted EPS (Rs.), as of Mar 25, the value is -7.55. This value is below the healthy minimum of 5. It has increased from -10.48 (Mar 24) to -7.55, marking an increase of 2.93.
- For Cash EPS (Rs.), as of Mar 25, the value is -3.22. This value is below the healthy minimum of 3. It has increased from -6.03 (Mar 24) to -3.22, marking an increase of 2.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.55. It has decreased from 36.55 (Mar 24) to 30.55, marking a decrease of 6.00.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.55. It has decreased from 36.55 (Mar 24) to 30.55, marking a decrease of 6.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 203.15. It has decreased from 217.08 (Mar 24) to 203.15, marking a decrease of 13.93.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -2.46. This value is below the healthy minimum of 2. It has increased from -6.69 (Mar 24) to -2.46, marking an increase of 4.23.
- For PBIT / Share (Rs.), as of Mar 25, the value is -6.64. This value is below the healthy minimum of 0. It has increased from -11.15 (Mar 24) to -6.64, marking an increase of 4.51.
- For PBT / Share (Rs.), as of Mar 25, the value is -9.80. This value is below the healthy minimum of 0. It has increased from -13.90 (Mar 24) to -9.80, marking an increase of 4.10.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -7.40. This value is below the healthy minimum of 2. It has increased from -10.48 (Mar 24) to -7.40, marking an increase of 3.08.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -7.40. This value is below the healthy minimum of 2. It has increased from -10.48 (Mar 24) to -7.40, marking an increase of 3.08.
- For PBDIT Margin (%), as of Mar 25, the value is -1.20. This value is below the healthy minimum of 10. It has increased from -3.08 (Mar 24) to -1.20, marking an increase of 1.88.
- For PBIT Margin (%), as of Mar 25, the value is -3.26. This value is below the healthy minimum of 10. It has increased from -5.13 (Mar 24) to -3.26, marking an increase of 1.87.
- For PBT Margin (%), as of Mar 25, the value is -4.82. This value is below the healthy minimum of 10. It has increased from -6.40 (Mar 24) to -4.82, marking an increase of 1.58.
- For Net Profit Margin (%), as of Mar 25, the value is -3.64. This value is below the healthy minimum of 5. It has increased from -4.82 (Mar 24) to -3.64, marking an increase of 1.18.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.64. This value is below the healthy minimum of 8. It has increased from -4.82 (Mar 24) to -3.64, marking an increase of 1.18.
- For Return on Networth / Equity (%), as of Mar 25, the value is -24.24. This value is below the healthy minimum of 15. It has increased from -28.68 (Mar 24) to -24.24, marking an increase of 4.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is -19.46. This value is below the healthy minimum of 10. It has increased from -26.59 (Mar 24) to -19.46, marking an increase of 7.13.
- For Return On Assets (%), as of Mar 25, the value is -4.11. This value is below the healthy minimum of 5. It has increased from -6.71 (Mar 24) to -4.11, marking an increase of 2.60.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.01, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.52 (Mar 24) to 0.65, marking an increase of 0.13.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.22. It has decreased from 1.41 (Mar 24) to 1.22, marking a decrease of 0.19.
- For Current Ratio (X), as of Mar 25, the value is 0.95. This value is below the healthy minimum of 1.5. It has decreased from 0.99 (Mar 24) to 0.95, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.52 (Mar 24) to 0.44, marking a decrease of 0.08.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.60. This value is below the healthy minimum of 4. It has increased from 2.34 (Mar 24) to 2.60, marking an increase of 0.26.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -9.53 (Mar 24) to 0.00, marking an increase of 9.53.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -16.59 (Mar 24) to 0.00, marking an increase of 16.59.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 109.53 (Mar 24) to 0.00, marking a decrease of 109.53.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 116.59 (Mar 24) to 0.00, marking a decrease of 116.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -0.77. This value is below the healthy minimum of 3. It has increased from -2.42 (Mar 24) to -0.77, marking an increase of 1.65.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.34. This value is below the healthy minimum of 3. It has increased from -2.80 (Mar 24) to -1.34, marking an increase of 1.46.
- For Enterprise Value (Cr.), as of Mar 25, the value is 89.51. It has decreased from 101.25 (Mar 24) to 89.51, marking a decrease of 11.74.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 24) to 0.45, marking a decrease of 0.03.
- For EV / EBITDA (X), as of Mar 25, the value is -37.27. This value is below the healthy minimum of 5. It has decreased from -15.80 (Mar 24) to -37.27, marking a decrease of 21.47.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 24) to 0.37, marking a decrease of 0.04.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 109.53 (Mar 24) to 0.00, marking a decrease of 109.53.
- For Price / BV (X), as of Mar 25, the value is 2.50. This value is within the healthy range. It has increased from 2.48 (Mar 24) to 2.50, marking an increase of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.41 (Mar 24) to 0.37, marking a decrease of 0.04.
- For EarningsYield, as of Mar 25, the value is -0.09. This value is below the healthy minimum of 5. It has increased from -0.11 (Mar 24) to -0.09, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aimco Pesticides Ltd:
- Net Profit Margin: -3.64%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -19.46% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -24.24% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 32.33)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.65
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -3.64%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | B-1/1, MIDC Industrial Area, Lote Parshuram, Village: Awashi, Ratnagiri Dist. Maharashtra 415707 | aimco@aimcopesticides.com http://www.aimcopesticides.com |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Samir Pradip Dave | Managing Director |
| Mr. Ashit Pradip Dave | Executive Director & CFO |
| Mr. Pradeep Pushkarrai Dave | Executive & Wholetime Director |
| Mrs. Elizabeth Chandraprakash Shrivastava | Whole Time Director |
| Mr. Mayoor Natubhai Amin | Chairman(NonExe.&Ind.Director) |
| Mr. Ashok Kumar Kundanmal Jain | Ind.& Non Exe.Director |
| Mr. Jagat Harish Shah | Ind.& Non Exe.Director |
| Mr. Jignesh Anantrai Nagodra | Ind. Non-Executive Director |